Search Results 591-600 of 16886 for Antagonist

1. Randomized Study To Assess The Safety, Pharmacokinetics/Dynamics Of DS-1040b In Subjects With Acute Submassive Pulmonary Embolism - Mayo Clinic

   Subjects receiving any vitamin K antagonists (VKAs) prior to randomization or receiving more than 36 hours treatment with LMW(low molecular weight Heparin) ...

2. Publications - Andrew S. Tseng, M.D. - Mayo Clinic

   Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation ...

3. Study to Evaluate the Pathophysiology of Multiple System Atrophy, Parkinson's Disease, Parkinson's Disease with Autonomic Failure and Dementia with Lewy Bodies Using Microneurographic Recordings of Muscle Sympathetic Nerve Activity - Mayo Clinic

   Concomitant therapy with anticholinergic, sympathomimetic, α- or β-adrenergic antagonists or agonists, or other medication which could interfere with testing of ...

4. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression - Mayo Clinic

   Treated with continuous androgen ablative therapy (either surgical castration or LHRH agonist/antagonist). Documented castrate level of serum testosterone ...

5. A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome - Mayo Clinic

   ... antagonist properties, including serotonin reuptake inhibition; atomoxetine, or other centrally-acting noradrenergic agonist; cyproheptadine, and/or ...

6. Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim 3) - Mayo Clinic

   Patients taking alpha antagonists or cytochrome P450 3A4 inhibitors (ketoconazole, itraconazole, erythromycin, saquinavir, cimetidine or serum proteases ...

7. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

   ... antagonists (eg, tirofiban) within 7 days of Screening; Use of erythropoietin stimulating agents within 7 days of Screening; Interferon (IFN) use within 14 ...

8. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

   ... antagonists (eg, tirofiban) within 7 days of Screening; Use of erythropoietin stimulating agents within 7 days of Screening; Interferon (IFN) use within 14 ...

9. A Study of the Effect of Liraglutide on Weight Loss and Stomach Functions in Obesity - Mayo Clinic

   For example, statins for hyperlipidemia, diuretics, β-adrenergic blockers,Angiotensin Converting Enzyme (ACE) inhibitors and angiotensin antagonists for ...

10. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

    Patient is receiving chronic oral anticoagulation therapy (i.e., vitamin K antagonist, direct thrombin inhibitor, Factor Xa inhibitor). Concomitant use of ...